Occidental Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Occidental Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,369	Closed	-$549K	–	220
2021 Q3	$549K	Buy	4,369 +94	+2%	+$12.1K	0.14%	137
2021 Q2	$579K	Buy	4,275 +1,900	+80%	+$250K	0.15%	136
2021 Q1	$322K	Buy	+2,375	New	+$356K	0.1%	156

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Occidental Asset Management's XBI Position: Q4 2021 in Review

Occidental Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 4,369 shares — an estimated $549K sold.

Occidental Asset Management first reported a position in XBI in Q1 2021 and held it in 3 quarters. The position peaked at $579K in Q2 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Occidental Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
Occidental Asset Management sold 4,369 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $549K.
Occidental Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 3 quarters.
Occidental Asset Management's State Street SPDR S&P Biotech ETF position peaked at $579K in Q2 2021.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Occidental Asset Management's 13F filing for Q4 2021, filed 1 Feb 2022.